TB-500

Marketed as a synthetic form of thymosin β-4 (Tβ4), a peptide the body makes that binds and regulates actin — one of the core building blocks of the cell skeleton. Shift actin dynamics and you influence how cells migrate, how new vessels form, and how inflammation settles at an injury, at least in animal models. One wrinkle the labels rarely mention: much of what is sold as "TB-500" is actually a shorter fragment of Tβ4, not the full molecule used in clinical research. We cover that fragment separately.

The real evidence sits with full-length thymosin β-4, which has been pushed into ongoing and projected human trials on four fronts: skin wound healing, corneal injury, cardiac repair after ischemic injury, and CNS recovery. That is not the generic "TB-500" sold to consumers — a research chemical with little independent verification that it even matches the clinically studied peptide. The animal data for tendon, muscle, and cardiac repair looks encouraging. Encouraging is not proven, and no completed human efficacy trial backs the injury-recovery uses people actually buy it for. Long-term human safety is a blank.

• Cell migration and new-vessel formation in wound-healing models (animal)
• Improved recovery in animal models of tendon, ligament, and muscle injury
• Cardioprotective and tissue-repair signals in preclinical heart-injury studies
• Early human trials of full Tβ4 for skin wounds and dry eye

• Consumer "TB-500" is often a fragment, not the clinically studied full peptide
• No completed human RCTs demonstrating the benefits people seek for injuries
• Pro-angiogenic activity is a theoretical concern in people with cancer
• Banned in sport by WADA
• Research-use-only sourcing means variable purity and dose accuracy

Research compound. Sold "for research use only" — not approved for human consumption.

Goals studied: Tendon & ligament repair, Muscle recovery

Is TB-500 the same as thymosin β-4?

Not necessarily. The clinically studied molecule is full-length thymosin β-4. Much of the "TB-500" sold to consumers is a shorter active fragment, which is why we keep a separate fragment profile.

Does TB-500 heal injuries in humans?

There are no completed human RCTs showing it heals the tendon or muscle injuries people use it for. The human-relevant evidence is early-phase and concerns the full Tβ4 molecule.

1. [1]
   Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications

   Goldstein AL, Hannappel E, Sosne G, Kleinman HK · Expert Opinion on Biological Therapy · 2012 · PMID 22074294 · model: animal

   Revue des rôles de la thymosine β4 dans la liaison à l'actine, la migration cellulaire et la réparation tissulaire, et de ses premières applications cliniques.

2. [2]
   Thymosin beta 4 promotes corneal wound healing and decreases inflammation in vivo following alkali injury

   Sosne G, Szliter EA, Barrett R, Kernacki KA, Kleinman H, Hazlett LD · Experimental Eye Research · 2002 · PMID 11950239 · model: animal

   Étude in vivo chez la souris montrant que la thymosine β4 topique accélère la ré-épithélialisation cornéenne et réduit l'inflammation après lésion.